{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:49:30Z","timestamp":1790732970497,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Sichuan Science and Technology Program Key R&D Project","award":["2023YFS0236"],"award-info":[{"award-number":["2023YFS0236"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"DOI":"10.1186\/s12931-026-03608-3","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T04:36:29Z","timestamp":1773030989000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Integrated multiomics profiling predicts anti-tuberculosis drug-induced liver injury"],"prefix":"10.1186","volume":"27","author":[{"given":"Quanxian","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaozhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"key":"3608_CR1","doi-asserted-by":"publisher","DOI":"10.54394\/CJQU6666","volume-title":"Global tuberculosis report 2024","author":"World Health Organization","year":"2024","unstructured":"World Health Organization. Global tuberculosis report 2024. Geneva: World Health Organization; 2024."},{"issue":"11","key":"3608_CR2","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41579-022-00731-y","volume":"20","author":"VA Dartois","year":"2022","unstructured":"Dartois VA, Rubin EJ. Anti-tuberculosis treatment strategies and drug development: challenges and priorities. Nat Rev Microbiol. 2022;20(11):685\u2013701.","journal-title":"Nat Rev Microbiol"},{"key":"3608_CR3","volume-title":"WHO consolidated guidelines on tuberculosis. Module 4: treatment-drug-susceptible tuberculosis treatment","author":"Who","year":"2022","unstructured":"Who. WHO consolidated guidelines on tuberculosis. Module 4: treatment-drug-susceptible tuberculosis treatment . Geneva: World Health Organization; 2022."},{"issue":"7","key":"3608_CR4","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1093\/cid\/ciw566","volume":"63","author":"P Nahid","year":"2016","unstructured":"Nahid P, Dorman SE, Alipanah N, et al. Executive Summary: Official American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. Clin Infect Dis. 2016;63(7):853\u201367.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"3608_CR5","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1111\/liv.14896","volume":"41","author":"F Jiang","year":"2021","unstructured":"Jiang F, Yan H, Liang L, et al. Incidence and risk factors of anti-tuberculosis drug induced liver injury (DILI): Large cohort study involving 4652 Chinese adult tuberculosis patients. Liver Int. 2021;41(7):1565\u201375.","journal-title":"Liver Int"},{"key":"3608_CR6","doi-asserted-by":"crossref","unstructured":"Beytout Q, Godefroy N, Monsel G et al. Clinical management of anti-tuberculosis related cutaneous adverse drug reactions based on reintroduction. J Travel Med. 2023;30(8):taad134.","DOI":"10.1093\/jtm\/taad134"},{"issue":"1","key":"3608_CR7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s15010-019-01324-3","volume":"48","author":"M El Hamdouni","year":"2020","unstructured":"El Hamdouni M, Ahid S, Bourkadi JE, et al. Incidence of adverse reactions caused by first-line anti-tuberculosis drugs and treatment outcome of pulmonary tuberculosis patients in Morocco. Infection. 2020;48(1):43\u201350.","journal-title":"Infection"},{"issue":"5","key":"3608_CR8","first-page":"343","volume":"42","author":"Branch CM. a T","year":"2019","unstructured":"Branch CM. a T. Guidelines for the diagnosis and treatment of antituberculosis drug-induced liver injury (2019 edition) . Chin J Tuberculosis Respiratory. 2019;42(5):343\u201356.","journal-title":"Chin J Tuberculosis Respiratory"},{"issue":"6","key":"3608_CR9","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1136\/gutjnl-2016-313369","volume":"66","author":"GA Kullak-Ublick","year":"2017","unstructured":"Kullak-Ublick GA, Andrade RJ, Merz M, et al. Drug-induced liver injury: recent advances in diagnosis and risk assessment. Gut. 2017;66(6):1154\u201364.","journal-title":"Gut"},{"issue":"1","key":"3608_CR10","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/INF.0000000000002192","volume":"38","author":"F Gafar","year":"2019","unstructured":"Gafar F, Arifin H, Jurnalis YD, et al. Antituberculosis Drug-induced Liver Injury in Children: Incidence and Risk Factors During the Two-month Intensive Phase of Therapy. Pediatr Infect Dis J. 2019;38(1):50\u20133.","journal-title":"Pediatr Infect Dis J"},{"issue":"9","key":"3608_CR11","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1111\/liv.15288","volume":"42","author":"S Ling","year":"2022","unstructured":"Ling S, Jiang G, Que Q, et al. Liver transplantation in patients with liver failure: Twenty years of experience from China. Liver Int. 2022;42(9):2110\u20136.","journal-title":"Liver Int"},{"key":"3608_CR12","doi-asserted-by":"crossref","unstructured":"Xie Z, Zhang L, Chen E et al. Targeted Metabolomics Analysis of Bile Acids in Patients with Idiosyncratic Drug-Induced Liver Injury. Metabolites. 2021;11(12):852.","DOI":"10.3390\/metabo11120852"},{"key":"3608_CR13","doi-asserted-by":"publisher","first-page":"109084","DOI":"10.1016\/j.intimp.2022.109084","volume":"111","author":"YZ Han","year":"2022","unstructured":"Han YZ, Ma ZT, Zhou MX, et al. Metabolomic profiling for drug-induced liver injury with autoantibodies. Int Immunopharmacol. 2022;111:109084.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"3608_CR14","doi-asserted-by":"publisher","first-page":"15138","DOI":"10.1038\/s41598-023-42312-w","volume":"13","author":"K He","year":"2023","unstructured":"He K, Liu M, Wang Q, et al. Combined analysis of 16S rDNA sequencing and metabolomics to find biomarkers of drug-induced liver injury. Sci Rep. 2023;13(1):15138.","journal-title":"Sci Rep"},{"key":"3608_CR15","doi-asserted-by":"publisher","first-page":"1044808","DOI":"10.3389\/fphar.2022.1044808","volume":"13","author":"MG Wang","year":"2022","unstructured":"Wang MG, Wu SQ, Zhang MM, et al. Plasma metabolomic and lipidomic alterations associated with anti-tuberculosis drug-induced liver injury. Front Pharmacol. 2022;13:1044808.","journal-title":"Front Pharmacol"},{"key":"3608_CR16","doi-asserted-by":"publisher","unstructured":"China NH, a F, P C O T P S R. O. Diagnostic criteria for tuberculosis (WS 288\u20132017). Electron J Emerg Infect Dis. 2018;3(1):59\u201361. https:\/\/doi.org\/10.3877\/j.issn.2096-2738.2018.01.017.","DOI":"10.3877\/j.issn.2096-2738.2018.01.017"},{"issue":"9","key":"3608_CR17","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1007\/s00125-008-1060-6","volume":"51","author":"AC Calkin","year":"2008","unstructured":"Calkin AC, Giunti S, Sheehy KJ, et al. The HMG-CoA reductase inhibitor rosuvastatin and the angiotensin receptor antagonist candesartan attenuate atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes via effects on advanced glycation, oxidative stress and inflammation. Diabetologia. 2008;51(9):1731\u201340.","journal-title":"Diabetologia"},{"issue":"3","key":"3608_CR18","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.jhep.2011.02.007","volume":"55","author":"M Garcia-Cortes","year":"2011","unstructured":"Garcia-Cortes M, Stephens C, Lucena MI, et al. Causality assessment methods in drug induced liver injury: strengths and weaknesses. J Hepatol. 2011;55(3):683\u201391.","journal-title":"J Hepatol"},{"key":"3608_CR19","doi-asserted-by":"crossref","unstructured":"Steinhoff JS, Lass A, Schupp M. Retinoid Homeostasis and Beyond: How Retinol Binding Protein 4 Contributes to Health and Disease. Nutrients. 2022;14(6):1236.","DOI":"10.3390\/nu14061236"},{"issue":"6","key":"3608_CR20","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1097\/MPA.0000000000001852","volume":"50","author":"F Yu","year":"2021","unstructured":"Yu F, Fu J, Zhang C, et al. Use of Chromogranin A for Monitoring Patients With Pancreatic Neuroendocrine Neoplasms. Pancreas. 2021;50(6):882\u20139.","journal-title":"Pancreas"},{"key":"3608_CR21","doi-asserted-by":"publisher","first-page":"110430","DOI":"10.1016\/j.cbi.2023.110430","volume":"375","author":"NTH Yen","year":"2023","unstructured":"Yen NTH, Oh JH, Van Anh NT, et al. Systems-level multi-omics characterization provides novel molecular insights into indomethacin toxicity. Chem Biol Interact. 2023;375:110430.","journal-title":"Chem Biol Interact"},{"issue":"1","key":"3608_CR22","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00204-019-02595-3","volume":"94","author":"L Zhang","year":"2020","unstructured":"Zhang L, Niu M, Wei AW, et al. Risk profiling using metabolomic characteristics for susceptible individuals of drug-induced liver injury caused by Polygonum multiflorum. Arch Toxicol. 2020;94(1):245\u201356.","journal-title":"Arch Toxicol"},{"issue":"7919","key":"3608_CR23","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41586-022-04949-x","volume":"607","author":"Y Yang","year":"2022","unstructured":"Yang Y, Nguyen M, Khetrapal V, et al. Within-host evolution of a gut pathobiont facilitates liver translocation. Nature. 2022;607(7919):563\u201370.","journal-title":"Nature"},{"key":"3608_CR24","doi-asserted-by":"crossref","unstructured":"Ji Y, Yin Y, Li Z et al. Gut Microbiota-Derived Components and Metabolites in the Progression of Non-Alcoholic Fatty Liver Disease (NAFLD). Nutrients. 2019;11(8):1712.","DOI":"10.3390\/nu11081712"},{"issue":"1","key":"3608_CR25","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s00018-023-05061-7","volume":"81","author":"KR Lefort","year":"2024","unstructured":"Lefort KR, Rungratanawanich W, Song BJ. Contributing roles of mitochondrial dysfunction and hepatocyte apoptosis in liver diseases through oxidative stress, post-translational modifications, inflammation, and intestinal barrier dysfunction. Cell Mol Life Sci. 2024;81(1):34.","journal-title":"Cell Mol Life Sci"},{"key":"3608_CR26","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/bs.apha.2019.02.001","volume":"85","author":"MR Mcgill","year":"2019","unstructured":"Mcgill MR, Jaeschke H. Biomarkers of drug-induced liver injury. Adv Pharmacol. 2019;85:221\u201339.","journal-title":"Adv Pharmacol"},{"key":"3608_CR27","doi-asserted-by":"crossref","unstructured":"Gong JY, Ren H, Chen HQ et al. Magnesium Isoglycyrrhizinate Attenuates Anti-Tuberculosis Drug-Induced Liver Injury by Enhancing Intestinal Barrier Function and Inhibiting the LPS\/TLRs\/NF-\u03baB Signaling Pathway in Mice. Pharmaceuticals (Basel). 2022;15(9):1130.","DOI":"10.3390\/ph15091130"},{"key":"3608_CR28","doi-asserted-by":"crossref","unstructured":"Li Y, Zhao L, Sun C et al. Regulation of Gut Microflora by Lactobacillus casei Zhang Attenuates Liver Injury in Mice Caused by Anti-Tuberculosis Drugs. Int J Mol Sci. 2023;24(11):9444.","DOI":"10.3390\/ijms24119444"},{"key":"3608_CR29","doi-asserted-by":"crossref","unstructured":"Szukalska I, Zietek M, Brodowski J et al. The Association Between Short-Chain Fatty Acids and the Incidence of Food Allergies-Systematic Review. Nutrients. 2025;17(19):3117.","DOI":"10.3390\/nu17193117"},{"key":"3608_CR30","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.3389\/fmicb.2020.01906","volume":"11","author":"MA Caillaud","year":"2020","unstructured":"Caillaud MA, Abeilhou M, Gonzalez I, et al. Precise Populations\u2019 Description in Dairy Ecosystems Using Digital Droplet PCR: The Case of L. lactis Group in Starters. Front Microbiol. 2020;11:1906.","journal-title":"Front Microbiol"},{"key":"3608_CR31","doi-asserted-by":"crossref","unstructured":"Hrncir T. Gut Microbiota Dysbiosis: Triggers, Consequences, Diagnostic and Therapeutic Options. Microorganisms. 2022;10(3):578.","DOI":"10.3390\/microorganisms10030578"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-026-03608-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-026-03608-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-026-03608-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T11:18:55Z","timestamp":1776251935000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12931-026-03608-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3608"],"URL":"https:\/\/doi.org\/10.1186\/s12931-026-03608-3","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]},"assertion":[{"value":"11 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of West China Hospital of Sichuan University, the Affiliated Hospital of Zunyi Medical University and Guangyuan People's Hospital [Approval No. KLL-2022-735]. The study was conducted with the written informed consent of each subject. The confidentiality of the data is maintained, and no identifiable information is collected. The study was carried out in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"169"}}